These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10160286)

  • 21. Effect of an educational outreach program on prescribing potential drug-drug interactions.
    Malone DC; Liberman JN; Sun D
    J Manag Care Pharm; 2013 Sep; 19(7):549-57. PubMed ID: 23964616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoting interprofessional collaboration: pharmacy students teaching current and future prescribers about Medicare Part D.
    Lai CJ; Smith AR; Stebbins MR; Cutler TW; Lipton HL
    J Manag Care Pharm; 2011; 17(6):439-48. PubMed ID: 21787029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promotion of OTC products within a network-model HMO.
    Gilderman A; Shinmoto M; Andrews S
    Med Interface; 1996 Jun; 9(6):104-8. PubMed ID: 10157923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of generic medication vouchers to a pharmacist academic detailing program: effects on the generic dispensing ratio in a physician-hospital organization.
    Bhargava V; Greg ME; Shields MC
    J Manag Care Pharm; 2010; 16(6):384-92. PubMed ID: 20635829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial risk relationships and adoption of management strategies in physician groups for self-administered injectable drugs.
    Agnew JD; Stebbins MR; Hickman DE; Lipton HL
    J Manag Care Pharm; 2003; 9(6):523-33. PubMed ID: 14664660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring drug use in an IPA-model HMO.
    Cohen P; Jay GT
    Am J Health Syst Pharm; 1996 Jul; 53(13):1534-6. PubMed ID: 8809271
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of prescriber education on the use of medications contraindicated in older adults in a managed medicare population.
    Kaufman MB; Brodin KA; Sarafian A
    J Manag Care Pharm; 2005 Apr; 11(3):211-9. PubMed ID: 15804205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reducing the volume of antibiotic prescriptions: a peer group intervention among physicians serving a community with special ethnic characteristics.
    Wilf-Miron R; Ron N; Ishai S; Chory H; Abboud L; Peled R
    J Manag Care Pharm; 2012 May; 18(4):324-8. PubMed ID: 22548692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and treatment of respiratory infections: does managed care make a difference?
    Hueston WJ; Mainous AG; Brauer N; Mercuri J
    J Fam Pract; 1997 Jun; 44(6):572-7. PubMed ID: 9191630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing cost effects of two quality strategies to improve test ordering in primary care: a randomized trial.
    Verstappen WH; van Merode F; Grimshaw J; Dubois WI; Grol RP; van der Weijden T
    Int J Qual Health Care; 2004 Oct; 16(5):391-8. PubMed ID: 15375100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
    Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
    Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and economic outcomes of conversion of simvastatin to lovastatin in a group-model health maintenance organization.
    Billups SJ; Plushner SL; Olson KL; Koehler TJ; Kerzee J
    J Manag Care Pharm; 2005 Oct; 11(8):681-6. PubMed ID: 16194132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of financial and educational incentives on rational prescribing. A state-space approach.
    Pechlivanoglou P; Wieringa JE; de Jager T; Postma MJ
    Health Econ; 2015 Apr; 24(4):439-53. PubMed ID: 24519732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
    Fretheim A; Aaserud M; Oxman AD
    PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug utilization review in an HMO. I. Introduction and examples of methodology.
    West SK; Brandon BM; Stevens AM; Zauber A; Chase G; Stolley PD; Rumrill RE
    Med Care; 1977 Jun; 15(6):505-14. PubMed ID: 17794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prescribing intention and the relative importance of drug attributes: a comparative study of HMO and fee-for-service physicians.
    Chinburapa V; Larson LN; Bootman JL; McGhan WF; Nichloson G
    J Pharm Mark Manage; 1987; 2(2):89-105. PubMed ID: 10287956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a DUR intervention: a case study of histamine antagonists.
    Zimmerman DR; Collins TM; Lipowski EE; Sainfort F
    Inquiry; 1994; 31(1):89-101. PubMed ID: 7909535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Provision of social norm feedback to high prescribers of antibiotics in general practice: a pragmatic national randomised controlled trial.
    Hallsworth M; Chadborn T; Sallis A; Sanders M; Berry D; Greaves F; Clements L; Davies SC
    Lancet; 2016 Apr; 387(10029):1743-52. PubMed ID: 26898856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safer Prescribing--A Trial of Education, Informatics, and Financial Incentives.
    Dreischulte T; Donnan P; Grant A; Hapca A; McCowan C; Guthrie B
    N Engl J Med; 2016 Mar; 374(11):1053-64. PubMed ID: 26981935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.